GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.

A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple ...

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...

QST team Members of the Imaging Physics Group with the total-body small-animal PET scanner. (Courtesy: Han Gyu Kang) Dynamic PET imaging is an important preclinical research tool used to visualize ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is ...

Long COVID patients with abnormal cardiopulmonary PET/MR findings may be more likely to develop heart and lung diseases ...

PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy and guides personalised cancer treatment effectively.

PET/CT scans using ⁶⁸Ga-FAPI detected activated fibroblasts in 64 percent of patients, with half showing patchy and half showing extensive heart uptake.

Cardiac amyloidosis (CA) is a progressive disease characterized by extracellular deposition of misfolded proteins, leading to myocardial dysfunction and poor prognosis. Early and accurate diagnosis ...

The use of targeted imaging agents in the myocardium has the potential to provide valuable insights into the pathophysiology of myocardial injury and to facilitate the development of novel ...

RUHX, the official charity of the Royal United Hospitals (RUH) Bath, has launched a £4 million appeal to fund a new PET-CT ...